Thyroid Supplementation Therapy

Thyroid Supplementation Therapy

Hypothyroidism, a condition in which the thyroid gland is not able to produce enough thyroid hormone, is more common than what you would believe. Unfortunately, millions of people are currently hypothyroid and don’t know it. Thyroid disease is a global health problem that can substantially impact the well-being, particularly in pregnancy and childhood.

Thyroid hormones are essential for growth, neuronal development, reproduction and regulation of energy metabolism. Since the main purpose of the thyroid hormone is to “run the body’s metabolism,” it is understandable that people with this condition will have symptoms associated with a slow metabolism.

The signs and symptoms of hypothyroidism vary, depending on the severity of the hormone deficiency. Problems tend to develop slowly, often over a number of years. At first, you may barely notice the symptoms of hypothyroidism, such as fatigue and weight gain. Or you may simply attribute them to getting older. But as your metabolism continues to slow down, you may develop more serious problems such as impaired memory, joint pain, anovulation, infertility, heart disease, among others.

Thyroid Replacement Therapy compensates for the lack of hormone secreted by your thyroid gland and is a very individualized treatment process that is highly effective when prescribed properly.

The most common replacement therapy for hypothyroidism is the institution of Levothyroxine (T4). However, for a subset of hypothyroid patients who has a polymorphism in the gene encoding the D2 enzyme, levothyroxine therapy alone does not provide full resolution of symptoms.

Revitalife Compounding Pharmacy offers combination of Liothyronine (T3), the potent and most active form of thyroid hormone, and Levothyroxine (T4), the long acting form of thyroid hormone. This combination of thyroid hormone provides both the potent effect and the long duration of action of the two (2) thyroid hormones. It also offers great benefit for most of the patient continue to experience nonspecific symptoms after Levothyroxine (T4) therapy alone

References:

  • Hertoghe T. The Hormone Handbook. 2nd Edition. IMB-Publications. 2010
  • Peter N. Taylor, Diana Albrecht, Anna Scholz, Gala Gutierrez-Buey, John H. Lazarus, Colin M. Dayan & Onyebuchi E. Okosieme. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018 May;14(5):301-316
  • McDermott MT. Does combination T4 and T3 therapy make sense? Endocr Pract. 2012 Sep-Oct;18(5):750-7
  • Bernadette Biondi, Leonard Wartofsky. Combination Treatment with T4 and T3: Toward Personalized Replacement Therapy in Hypothyroidism? The Journal of Clinical Endocrinology & Metabolism, Volume 97, Issue 7, 1 July 2012, Pages 2256–2271

In over 30 years, MEDISCA has developed a solid reputation as an innovative and and entrepreurial company in the pharmaceutical compounding industry. MEDISCA is a leading FDA-registered supplier of quality pharmacy compounding products, such as Active Pharmaceutical Ingredients, Devices & Equipment, Excipients, Bases and Vehicles and Fine Chemicals. MEDISCA is known for their excellent service and their three distribution centers which are fully stocked to support your compounding needs.